Published by Nicolas Tierney
June 27, 2019
Regenerative medicine, broadly defined, is one of this century’s major medical trends. Its “value” is estimated conservatively in excess of $100 billion, with substantial growth forecast for many decades. Much of this value will inevitably accrue to product manufacturers and other non-practitioners. However, it should also accrue to those clinicians delivering evidence-based and regulatorily-compliant regenerative medicine procedures (“RMP’s”).
Read The Latest
November 11, 2020
RMSNY is a product-agnostic organization led by internationally recognized scientific and clinical thought leaders. Its clinical members ...
June 16, 2020
The power of regenerative medicine to heal, and prevent, a broad range of diseases and conditions has been recognized by major governments and medical ...